JSSH(SZ:000518)2015-05-05 16:00Revenue and Profit - Revenue for Q1 2015 was CNY 46,987,464.09, a decrease of 37.14% compared to CNY 74,755,076.02 in the same period last year[8] - Net profit attributable to shareholders was CNY 10,098,042.27, down 21.31% from CNY 12,833,227.70 year-over-year[8] - Basic and diluted earnings per share decreased to CNY 0.0098, down 21.60% from CNY 0.0125[8] - Operating revenue decreased by 37.14% to ¥46,987,464.09, reflecting a sales decline for Beijing and Jiangsu Sihuan Biopharmaceutical[15] - Operating profit for the current period is ¥11,541,290.75, compared to ¥15,124,626.46 in the previous period, reflecting a decrease of approximately 23.5%[35] - Net profit for the current period is ¥9,651,125.86, down from ¥11,532,617.73 in the previous period, which is a decline of about 16.3%[36] - The company reported a total comprehensive income of ¥9,651,125.86 for the current period, down from ¥11,532,617.73 in the previous period, a decrease of about 16.3%[40] Cash Flow - Net cash flow from operating activities improved significantly to CNY 740,056.43, a 225.15% increase from a negative CNY 591,346.92 in the previous year[8] - Cash flow from operating activities is ¥53,775,445.75, down from ¥67,242,194.17 in the previous period, indicating a decline of approximately 20%[42] - The net cash flow from operating activities was CNY 740,056.43, a significant improvement compared to a net outflow of CNY 591,346.92 in the previous period[43] - Total cash outflow from operating activities amounted to CNY 53,035,389.32, down from CNY 67,833,541.09 year-over-year[43] - Cash inflow from financing activities reached CNY 35,000,000.00, compared to CNY 0.00 in the previous period, indicating successful fundraising efforts[44] - The net cash flow from financing activities was CNY 33,968,977.25, a substantial increase from a net outflow of CNY 2,510,470.23 in the previous period[44] Assets and Liabilities - Total assets at the end of the reporting period were CNY 848,931,843.93, reflecting a 3.77% increase from CNY 818,082,450.17 at the end of the previous year[8] - Current liabilities rose to CNY 112,707,476.24 from CNY 91,598,208.34, an increase of about 23%[28] - The total liabilities increased to CNY 117,688,780.15 from CNY 96,490,512.25, reflecting a growth of approximately 22%[28] - The total equity attributable to shareholders increased to CNY 691,165,638.75 from CNY 681,067,596.48, a rise of about 1.6%[29] - The company reported an accumulated deficit of CNY -402,443,484.81, slightly improved from CNY -412,541,527.08[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 179,106[11] - The largest shareholder, Guangzhou Shengjing Investment Co., Ltd., held 3.89% of shares, amounting to 40,000,000 shares, with some shares pledged[11] - There were no significant changes in the shareholding structure or any repurchase transactions among the top ten shareholders during the reporting period[12] Expenses - Operating costs fell by 34.82% to ¥16,995,134.75, corresponding to the decrease in operating revenue[15] - The company reported a 48.14% decrease in income tax expenses to ¥1,880,600.73, linked to reduced profits[15] - Sales expenses for the current period are ¥1,986,607.25, significantly reduced from ¥10,913,165.22 in the previous period, a decrease of about 81.8%[35] - Management expenses decreased to ¥17,185,214.54 from ¥19,135,634.73, reflecting a reduction of approximately 10.2%[35] Other Financial Information - The company reported non-recurring losses totaling CNY 6,214.29 during the reporting period[9] - The company did not hold any securities investments during the reporting period[19] - The company has no short-term or long-term borrowings reported[28][32] - The total non-current liabilities slightly increased to CNY 4,981,303.91 from CNY 4,892,303.91, a growth of about 1.8%[28] - The first quarter report was not audited, indicating that the figures may be subject to change upon final review[49]